Novel Innovations Made by Doctors at The Ground Level
Since 2014, we have built a robust USPTO patent portfolio focused on local anesthetics and periodontal innovations. Our expertise spans advanced anesthesia drugs, nanoparticle formulations, and periodontal AI software for digital diagnosis and treatment planning.
​
Our company's intellectual property derives its value from its high barriers to entry, specialized knowledge in know-how nanoparticles formulation technology, its utility comparison, global growth market opportunity, legal patent protection, and new and upcoming anticancer nanoparticles formulation technology.
First-of-its-kind Periodontal Device
We can’t ignore the fact that across the globe, periodontitis is the single most prevalent chronic infectious disease.
​
Our novel periodontal methods and system are expected to reshape nearly every aspect of localized periodontal therapy with the potential to significantly impact the global market.
Nanoparticle Formulation Technology
Prefilled & Disposable Medical Device Solutions
We develop products for niche dental and medical markets with significant unmet needs. To differentiate ourselves from competitors, certain product candidates target novel indications with unprecedented labeling claims. Since we began operations in 2014, we have devoted substantially all of our resources to research and development in periodontal care, anesthetics, nanoparticle drug formulations, and prefilled medical devices.
We Take Pride in Our Numbers & Technology
12
Years of Experience
2
Finished Products
5
Candidate Products
1
FDA Clearance
50+
Patents & Claims
Our latest growth
We understand FDA legislative issues, but more importantly, we keep up to date on various policy
With our finished and candidate product's comprehensive regulatory strategies in hand, we fully understand the expectations, carefully evaluate potential hurdles, and create master plans to proactively address them early in development.
​
Our master plan informs the entire development program. For example, elements from the regulatory strategic documents drive the medical device and drug plans, identifying issues that affect both design requirements and the associated budget.
Having a good understanding of the clinical, and technical development requirements—as well as timelines, achievable commercial claims, risks, and regulatory mechanisms to enhance product value and accelerated approval pathways are extremely helpful in designing an efficient early development pathway, assessing the value of the product, and knowing how far our company can proceed before needing additional financing or a partner.